ENTRY       D02689                      Drug
NAME        Ramelteon (JAN/USAN/INN);
            Rozerem (TN)
PRODUCT     ROZEREM (Takeda Pharmaceuticals America)
  GENERIC   RAMELTEON (Actavis Pharma)
            RAMELTEON (Advanced Rx Pharmacy of Tennessee)
            RAMELTEON (Advanced Rx Pharmacy of Tennessee)
            RAMELTEON (American Health Packaging)
            RAMELTEON (Aurobindo Pharma Limited)
            RAMELTEON (AvKARE)
            RAMELTEON (AvPAK)
            RAMELTEON (Bryant Ranch Prepack)
            RAMELTEON (Bryant Ranch Prepack)
            RAMELTEON (Bryant Ranch Prepack)
            RAMELTEON (Bryant Ranch Prepack)
            RAMELTEON (DIRECT RX)
            RAMELTEON (Direct_Rx)
            RAMELTEON (Direct_Rx)
            RAMELTEON (Dr.Reddys Laboratories)
            RAMELTEON (Granules Pharmaceuticals)
            RAMELTEON (Micro Labs Limited)
            RAMELTEON (Proficient Rx LP)
            RAMELTEON (Quality Care Products)
            RAMELTEON (TruPharma)
            RAMELTEON (Unit Dose Services)
            RAMELTEON (Upsher-Smith Laboratories)
            RAMELTEON (Westminster Pharmaceuticals)
            RAMELTEON (Xiromed)
            RAMELTEON (Zydus Lifesciences Limited)
            RAMELTEON (Zydus Pharmaceuticals USA)
            RAMELTEON (i3 Pharmaceuticals)
FORMULA     C16H21NO2
EXACT_MASS  259.1572
MOL_WEIGHT  259.3434
CLASS       Neuropsychiatric agent
             DG01589  Melatonin receptor agonist
             DG03202  Hypnotic
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
REMARK      Therapeutic category: 1190
            ATC code: N05CH02
            Product: D02689<JP/US>
EFFICACY    Hypnotic, Melatonin receptor agonist
  DISEASE   Insomnia [DS:H01609]
COMMENT     Treatment of sleep disorders
TARGET      MTNR1 [HSA:4543 4544] [KO:K04285 K04286]
  PATHWAY   hsa04080(4543+4544)  Neuroactive ligand-receptor interaction
            hsa04713(4543+4544)  Circadian entrainment
METABOLISM  Enzyme: CYP1A2 [HSA:1544]
INTERACTION  
STR_MAP     map07032  Hypnotics
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N05 PSYCHOLEPTICS
               N05C HYPNOTICS AND SEDATIVES
                N05CH Melatonin receptor agonists
                 N05CH02 Ramelteon
                  D02689  Ramelteon (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Sleep Disorder Agents
              Sleep Promoting Agents
               Ramelteon
                D02689  Ramelteon (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               119  Miscellaneous
                1190  Miscellaneous
                 D02689  Ramelteon (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01589  Melatonin receptor agonist
               D02689  Ramelteon
              DG03202  Hypnotic
               D02689  Ramelteon
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               D02689  Ramelteon
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG03202  Hypnotic
               D02689  Ramelteon
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Melatonin
                MTNR1
                 D02689  Ramelteon (JAN/USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D02689
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D02689
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D02689
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D02689
DBLINKS     CAS: 196597-26-9
            PubChem: 17396858
            PDB-CCD: JEV
            LigandBox: D02689
ATOM        19
            1   C8y C    20.8600  -14.7700
            2   C8x C    20.8600  -16.1700
            3   C8x C    22.0724  -16.8700
            4   C8y C    23.2849  -16.1700
            5   C8y C    23.2849  -14.7700
            6   C8y C    22.0724  -14.0700
            7   C1x C    21.7814  -12.7006
            8   C1x C    20.3890  -12.5542
            9   O2x O    19.8196  -13.8332
            10  C1x C    24.6164  -16.6026
            11  C1x C    25.4393  -15.4700
            12  C1y C    24.6164  -14.3374
            13  C1b C    25.0475  -13.0106
            14  C1b C    26.2724  -12.3200
            15  N1b N    27.4849  -13.0200
            16  C5a C    28.6973  -12.3200
            17  C1b C    29.9097  -13.0200
            18  C1a C    31.1222  -12.3200
            19  O5a O    28.6973  -10.9200
BOND        21
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     6   7 1
            8     7   8 1
            9     8   9 1
            10    1   9 1
            11    4  10 1
            12   10  11 1
            13   11  12 1
            14    5  12 1
            15   12  13 1 #Down
            16   13  14 1
            17   14  15 1
            18   15  16 1
            19   16  17 1
            20   17  18 1
            21   16  19 2
///
